I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Ikeda, Takaya
235
results:
Search for persons
X
Format
Online (235)
Mediatypes
Articles (Online) (147)
Bookchapter (Online) (2)
OpenAccess-fulltext (86)
Sorted by: Relevance
Sorted by: Year
?
1
Pharmacokinetic and dose‐finding study of osimertinib in pa..:
Fujiwara, Yutaka
;
Makihara, Reiko
;
Hase, Tetsunari
...
Cancer Science. 114 (2023) 5 - p. 2087-2097 , 2023
Link:
https://doi.org/10.1111/..
?
2
552. Effect of Lactococcus lactis strain plasma (LC- Plasma..:
Yamamoto, Kazuko
;
Inoue, Tsuyoshi
;
Jounai, Kenta
...
Open Forum Infectious Diseases. 10 (2023) Supplement_2 - p. , 2023
Link:
https://doi.org/10.1093/..
?
3
Large-scale clinico-genomic profile of non-small cell lung ..:
Tamiya, Yutaro
;
Matsumoto, Shingo
;
Zenke, Yoshitaka
...
Lung Cancer. 176 (2023) - p. 103-111 , 2023
Link:
https://doi.org/10.1016/..
?
4
Clinicogenomic Features and Targetable Mutations in NSCLCs ..:
Sakai, Tetsuya
;
Matsumoto, Shingo
;
Ueda, Yasuto
...
Journal of Thoracic Oncology. 18 (2023) 11 - p. 1538-1549 , 2023
Link:
https://doi.org/10.1016/..
?
5
Phase II study of IRInotecan treatment after COmbined chemo..:
Tomono, Hiromi
;
Taniguchi, Hirokazu
;
Fukuda, Minoru
...
Thoracic Cancer. 14 (2023) 28 - p. 2890-2894 , 2023
Link:
https://doi.org/10.1111/..
?
6
Immune complexome analysis of serum samples from non-small-..:
Aizawa, Rika
;
Nakamura, Yoichi
;
Ikeda, Takaya
...
Clinica Chimica Acta. 532 (2022) - p. 84-88 , 2022
Link:
https://doi.org/10.1016/..
?
7
Phase I study of amrubicin plus cisplatin and concurrent ac..:
Akagi, Kazumasa
;
Taniguchi, Hirokazu
;
Fukuda, Minoru
...
Thoracic Cancer. 13 (2022) 16 - p. 2404-2409 , 2022
Link:
https://doi.org/10.1111/..
?
8
Impact of concomitant medication on clinical outcomes in pa..:
Miura, Kaho
;
Sano, Yoshiyuki
;
Niho, Seiji
...
Thoracic Cancer. 12 (2021) 13 - p. 1983-1994 , 2021
Link:
https://doi.org/10.1111/..
?
9
High proportion of tumor necrosis predicts poor survival in..:
Sugimoto, Akira
;
Umemura, Shigeki
;
Miyoshi, Tomohiro
...
Lung Cancer. 157 (2021) - p. 1-8 , 2021
Link:
https://doi.org/10.1016/..
?
10
The CLIP1–LTK fusion is an oncogenic driver in non‐small‐ce..:
Izumi, Hiroki
;
Matsumoto, Shingo
;
Liu, Jie
...
Nature. 600 (2021) 7888 - p. 319-323 , 2021
Link:
https://doi.org/10.1038/..
?
11
Amrubicin in previously treated patients with malignant ple..:
Ikeda, Takaya
;
Takemoto, Shinnosuke
;
Senju, Hiroaki
...
Thoracic Cancer. 11 (2020) 7 - p. 1972-1978 , 2020
Link:
https://doi.org/10.1111/..
?
12
Morphological, immune and genetic features in biopsy sample..:
Sakai, Tetsuya
;
Udagawa, Hibiki
;
Matsumoto, Shingo
...
Journal of Cancer Research and Clinical Oncology. 147 (2020) 4 - p. 1227-1237 , 2020
Link:
https://doi.org/10.1007/..
?
13
Dose escalation study of amrubicin and cisplatin with concu..:
Shimada, Midori
;
Yamaguchi, Hiroyuki
;
Fukuda, Minoru
...
Cancer Chemotherapy and Pharmacology. 84 (2019) 5 - p. 1059-1064 , 2019
Link:
https://doi.org/10.1007/..
?
14
Phase II study of ramucirumab and docetaxel for previously ..:
Takemoto, Shinnosuke
;
Fukuda, Minoru
;
Yamaguchi, Hiroyuki
...
Thoracic Cancer. 11 (2019) 2 - p. 389-393 , 2019
Link:
https://doi.org/10.1111/..
?
15
Phase II trial of a non‐platinum triplet for patients with ..:
Takemoto, Shinnosuke
;
Nakamura, Yoichi
;
Gyoutoku, Hiroshi
...
Thoracic Cancer. 10 (2019) 3 - p. 452-458 , 2019
Link:
https://doi.org/10.1111/..
1-15